• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Orange Book: Approved Drug Products with Therapeutic Equivalence Evaluations

  • Print
  • Share
  • E-mail
-

Patent and Exclusivity Search Results from query on Appl No 022309 Product 002 in the OB_Rx list.


Patent Data

Appl No Prod No Patent No Patent
Expiration
Drug Substance
Claim
Drug Product
Claim
Patent Use
Code
Delist
Requested
N022309 002 6503894 Aug 30, 2020 U - 1103
N022309 002 8466136 Oct 12, 2026 Y
N022309 002 8466137 Oct 12, 2026 U - 1103
N022309 002 8466138 Oct 12, 2026 U - 1103
N022309 002 8486925 Oct 12, 2026 Y
N022309 002 8729057 Oct 12, 2026 Y
N022309 002 8741881 Oct 12, 2026 U - 1103
N022309 002 8754070 Oct 12, 2026 Y
N022309 002 8759329 Oct 12, 2026 Y

Exclusivity Data

Appl No Prod No Exclusivity Code Exclusivity Expiration
N022309 002 NP Apr 29, 2014


Additional information:

  1. Patents are published upon receipt by the Orange Book Staff and may not reflect the official receipt date as described in 21 CFR 314.53(d)(5).
  2. Patents listed prior to August 18, 2003 are flagged with method of use claims only as applicable and submitted by the sponsor. These patents may not be flagged with respect to other claims which may apply.


View a list of all patent use codes
View a list of all exclusivity codes

Return to Electronic Orange Book Home Page


FDA/Center for Drug Evaluation and Research
Office of Generic Drugs
Division of Labeling and Program Support
Update Frequency:

Orange Book Data - Monthly
Generic Drug Product Information & Patent Information - Daily
Orange Book Data Updated Through October 2014
Patent and Generic Drug Product Data Last Updated November 21, 2014

-
-